ACHE and Alzheimer disease: Galantamine easily penetrates the blood–brain barrier (BBB), inhibits AChE in the cerebral cortex, and has a good improvement effect in patients with AD; however, its efficacy is relatively weak, so it is only suitable for the early treatment of mild and moderate AD [24].